[Retracted] Detection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer

Table 3

Association of the BRCA1/2-mutations with clinicopathologic characteristics in 141 ovarian cancer patients.

Clinicopathologic characteristics	BRCA1/2-mutation; Type (cases)	BRCA1/2-wild type (cases)	value
Age (year)			0.218
≤40	7.4% (2/27)	4.4% (5/114)
40-49	37% (10/27)	21.0% (24/114)
50-59	37% (10/27)	44.8% (51/114)
≥60	18.5% (5/27)	29.8% (34/114)
FIGO staging			0.649
I-II	18.5% (5/27)	16.7% (19/114)
III-IV	77.8% (21/27)	64.9% (74/114)
Unknown	3.7% (1/27)	18.4% (21/114)
Serum CA125			0.426
High	81.5% (22/27)	77.2% (88/114)
Normal	18.5% (5/27)	22.8% (26/114)
Family history			0.134
Presence	14.8% (4/27)	6.1% (7/114)
Absence	85.2% (23/27)	93.9% (107/114)
Personal history			0.682
Presence	14.8% (4/27)	4.4% (5/114)
Absence	85.2% (23/27)	95.6% (109/114)
Distant metastasis			0.002
Presence	70.4% (19/27)	37.7% (43/114)
Absence	29.6% (8/27)	62.3% (71/114)
Ki67 protein			0.869
Positive	66.7% (18/27)	45.6% (52/114)
Negative	11.1% (3/27)	13.2% (15/114)
Unknown	22.2% (6/27)	41.2% (47/114)